Protection from obesity-induced insulin resistance in mice lacking TNF-α function
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Obesity is highly associated with insulin resistance and is the biggest risk factor for non-insulin-dependent diabetes mellitus. The molecular basis of this common syndrome, however, is poorly understood. It has been suggested that tumour necrosis factor (TNF)-alpha is a candidate mediator of insulin resistance in obesity, as it is overexpressed in the adipose tissues of rodents and humans and it blocks the action of insulin in cultured cells and whole animals. To investigate the role of TNF-alpha in obesity and insulin resistance, we have generated obese mice with a targeted null mutation in the gene encoding TNF-alpha and those encoding the two receptors for TNF-alpha. The absence of TNF-alpha resulted in significantly improved insulin sensitivity in both diet-induced obesity and that resulting for the ob/ob model of obesity. The TNFalpha-deficient obese mice had lower levels of circulating free fatty acids, and were protected from the obesity-related reduction in the insulin receptor signalling in muscle and fat tissues. These results indicate that TNF-alpha is an important mediator of insulin resistance in obesity through its effects on several important sites of insulin action.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a number of animal studies where inflammatory pathways are genetically down regulated demonstrate that preventing obesity induced inflammation can prevent the development of insulin resistance [159,160].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [159]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Self-citationRole of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728 · cited 1×
“gif" NDATA ITEM> ]> Obesity is highly associated with insulin resistance and is the biggest risk factor for non-insulin-dependent diabetes mellitu”
BackgroundWhite, M. F., & Kahn, C. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42297-6 · Cited by 1,723
Kern, P. A., Saghizadeh, M., Ong, J. M., Bosch, R. J., Deem, R., & Simsolo, R. B. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117899 · Cited by 1,305
Tumor necrosis factor alpha inhibits signaling from the insulin receptor.
Hotamisligil, G. S., Murray, D. L., Choy, L. N., & Spiegelman, B. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4854 · Cited by 1,199
The Mouse in Biomedical Research
(1983) · Elsevier eBooks · doi:10.1016/c2013-0-10677-0 · Cited by 1,012
Bruce, A. J., Boling, W., Kindy, M. S., Peschon, J., Kraemer, P. J., Carpenter, M. K., Holtsberg, F. W., & Mattson, M. P. (1996) · Nature Medicine · doi:10.1038/nm0796-788 · Cited by 932 · cited 1×
“To test the importance of the TNFα-activated pathway of insulin resistance in the most severe, genetic model of obesity, we generated genetically obese ( ob/ob ) mice with targeted mutations in both p55 and p75 TNF receptors, effectively abolishing the signalling and function of TNF-α in these animal”
BackgroundHotamisligil, G. S., Johnson, R. S., Distel, R. J., Ellis, R., Papaioannou, V. E., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.274.5291.1377 · Cited by 918
Research works printed but not linked: 1
- Olefsky, J. M. & Molina, J. M. in Diabetes Mellitus (eds Rifkin, H. & Porte, D. J.) 121–153 (Elsevier, New York, (1990)).
Cited by
Items 401–500 of 1,010
Type 2 diabetes mellitus: a disease of the innate immune system? An update
Crook, M. (2004) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01030.x · Cited by 179
Obesity-associated Breast Cancer: Analysis of risk factors
Engin, A. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-48382-5_25 · Cited by 178
Nakanishi, N., Nakagawa, Y., Tokushige, N., Aoki, N., Matsuzaka, T., Ishii, K., Yahagi, N., Kobayashi, K., Yatoh, S., Takahashi, A., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.058 · Cited by 178
Ranganathan, G., Unal, R., Pokrovskaya, I., Yao-Borengasser, A., Phanavanh, B., Lecka-Czernik, B., Rasouli, N., & Kern, P. A. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600248-jlr200 · Cited by 178
Matsumoto, M., Ogawa, W., Akimoto, K., Inoue, H., Miyake, K., Furukawa, K., Hayashi, Y., Iguchi, H., Matsuki, Y., Hiramatsu, R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18816 · Cited by 178
“TNF-α secreted from adipose tissue is implicated in the development of obesity-induced insulin resistance (38).”
BackgroundBadawi (2010) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmsott.s9089 · Cited by 177
Protective Effects of (E)-β-Caryophyllene (BCP) in Chronic Inflammation
Scandiffio, R., Geddo, F., Cottone, E., Querio, G., Antoniotti, S., Gallo, M. P., Maffei, M. E., & Bovolin, P. (2020) · Nutrients · doi:10.3390/nu12113273 · Cited by 177
“Nowadays, almost 30 years later, the link between obesity, diabetes and chronic inflammation has been confirmed [93,109] and it has been also proved that mice lacking functional TNF-α are more insulin sensitive and glucose tolerant than wild type animals [106,110].”
BackgroundChan, S. M. H., Selemidis, S., Bozinovski, S., & Vlahos, R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.013 · Cited by 177
“Systemic elevation of TNF-α (Uysal, Wiesbrock, Marino, & Hotamisligil, 1997) and IL-6 (Cai et al., 2005) have been shown to promote insulin resistance particularly in the context of obesity.”
BackgroundDisruption of CXC Motif Chemokine Ligand-14 in Mice Ameliorates Obesity-induced Insulin Resistance
Nara, N., Nakayama, Y., Okamoto, S., Tamura, H., Kiyono, M., Muraoka, M., Tanaka, K., Taya, C., Shitara, H., Ishii, R., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700412200 · Cited by 176
Cruz, M. L., Shaibi, G. Q., Weigensberg, M. J., Spruijt-Metz, D., Ball, G. D. C., & Goran, M. I. (2005) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.25.050304.092625 · Cited by 176
Hypoxia-induced inflammatory cytokine secretion in human adipose tissue stromovascular cells
O’Rourke, R. W., White, A. E., Metcalf, M. D., Olivas, A. S., Mitra, P., Larison, W. G., Cheang, E. C., Varlamov, O., Corless, C. L., Roberts, C. T., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2103-y · Cited by 175
“TNF-α is a central proinflammatory and diabetogenic mediator in obesity [23–25].”
IGF-1 is downregulated in experimental cancer cachexia
Costelli, P., Muscaritoli, M., Bossola, M., Penna, F., Reffo, P., Bonetto, A., Busquets, S., Bonelli, G., Lopez-Soriano, F. J., Doglietto, G. B., et al. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00104.2006 · Cited by 175
“TNF- , in particular, has been proposed to be involved in the development of the insulin resistance that often complicates the management of neoplastic patients (43, 46), whereas the peripheral insulin resistance that develops in diet-induced obesity is less severe in TNF- knockout mice than in their normal counterpar…”
BackgroundAnimal models of steatohepatitis
Koteish, A., & Mae Diehl, A. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0332 · Cited by 175
Systemic inflammation and insulin sensitivity in obese IFN-γ knockout mice
O'Rourke, R. W., White, A. E., Metcalf, M. D., Winters, B. R., Diggs, B. S., Zhu, X., & Marks, D. L. (2012) · Metabolism · doi:10.1016/j.metabol.2012.01.018 · Cited by 174
“TNF-α, IL-10, CCL2, and IL-6 have been implicated in adipose tissue inflammation [1,5,22–30].”
BackgroundSchäfer, K., Fujisawa, K., Konstantinides, S., & Loskutoff, D. J. (2001) · The FASEB Journal · doi:10.1096/fj.00-0750fje · Cited by 174
“Moreover, ob/ob mice lacking TNF-α receptors have decreased plasma levels of PAI-1 and insulin, and decreased PAI-1 and TGF-β mRNAs in the adipose tissue (22, 23).”
BackgroundBogan, J. S., & Lodish, H. F. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.3.609 · Cited by 174
“ACRP30 likely also plays an important role in energy homeostasis, since it is dysregulated in obesity and has close structural homology to TNF-(cid:97) , another protein secreted by adipocytes and implicated in insulin resistance (Hu et al., 1996; Uysal et al., 1997; Shapiro and Scherer, 1998).”
BackgroundBoord, J. B., Maeda, K., Makowski, L., Babaev, V. R., Fazio, S., Linton, M. F., & Hotamisligil, G. S. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000033090.81345.e6 · Cited by 174
The Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction
Packer, M. (2025) · JACC · doi:10.1016/j.jacc.2025.06.055 · Cited by 173
Solas, M., Milagro, F. I., Ramírez, M. J., & Martínez, J. A. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.10.005 · Cited by 173
Woo, M., Jeon, S., Shin, Y. C., Lee, M., Kang, M. A., & Choi, M. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900079 · Cited by 173
“Although diet-induced obese animals are considered a more comparable model for human obesity than genetically obese animals [19], the molecular mechanism of fucoxanthin for anti-obesity has not been elucidated in diet-induced obesity.”
BackgroundJové, M., Planavila, A., Sánchez, R. M., Merlos, M., Laguna, J. C., & Vázquez-Carrera, M. (2006) · Endocrinology · doi:10.1210/en.2005-0440 · Cited by 172
Bakiri, L., & Wagner, E. F. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.01.005 · Cited by 172
“…core of the association between obesity and insulin resistance, a key contributor in the development of obesity-related HCC. Loss of TNF-a function improves insulin sensitivity in obesemice, possibly through interaction with insulin receptor signaling (Hotamisligil et al., 1994;Uysal et al., 1997).”
BackgroundObesity and diabetes in TNF-alpha receptor- deficient mice.
Schreyer, S. A., Chua, S. C., & LeBoeuf, R. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2849 · Cited by 172
cJun NH2-terminal kinase 1 (JNK1): Roles in metabolic regulation of insulin resistance
Sabio, G., & Davis, R. J. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.04.004 · Cited by 170
“Fourth, HFD-induced insulin resistance is associated with chronic low-grade inflammation and expression of inflammatory cytokines that can cause JNK activation [8], including tumor necrosis factor [24].”
BackgroundInsulin Resistance and Cancer: In Search for a Causal Link
Chiefari, E., Mirabelli, M., La Vignera, S., Tanyolaç, S., Foti, D. P., Aversa, A., & Brunetti, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011137 · Cited by 170
Non-alcoholic steatohepatitis: a microbiota-driven disease
Moschen, A. R., Kaser, S., & Tilg, H. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.05.009 · Cited by 170
Wu, T. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.1.65 · Cited by 170
The impact of reactive oxygen species in the development of cardiometabolic disorders: a review
Akhigbe, R. E., & Ajayi, A. F. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01435-7 · Cited by 186
Carey, A. L., Bruce, C. R., Sacchetti, M., Anderson, M. J., Olsen, D. B., Saltin, B., Hawley, J. A., & Febbraio, M. A. (2004) · Diabetologia · doi:10.1007/s00125-004-1403-x · Cited by 170
“In contrast with many studies [3, 4, 5], these results show that despite the markedly different rates of glucose infusion when comparing our populations, there was no evidence that TNFα Interleukin-6 and tumor necrosis factor-α are not increased in patients with Type 2 diabetes 1033”
Local proliferation initiates macrophage accumulation in adipose tissue during obesity
Zheng, C., Yang, Q., Cao, J., Xie, N., Liu, K., Shou, P., Qian, F., Wang, Y., & Shi, Y. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.54 · Cited by 169
POMC Neurons: From Birth to Death
Toda, C., Santoro, A., Kim, J. D., & Diano, S. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034110 · Cited by 168
Xu, J., Zhao, Y. H., Chen, Y. P., Yuan, X. L., Wang, J., Zhu, H., & Lu, C. M. (2014) · The Scientific World Journal · doi:10.1155/2014/926932 · Cited by 168
Badeanlou, L., Furlan-Freguia, C., Yang, G., Ruf, W., & Samad, F. (2011) · Nature Medicine · doi:10.1038/nm.2461 · Cited by 168
IL-1 Signaling in Obesity-Induced Hepatic Lipogenesis and Steatosis
Negrin, K. A., Roth Flach, R. J., DiStefano, M. T., Matevossian, A., Friedline, R. H., Jung, D., Kim, J. K., & Czech, M. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107265 · Cited by 168
Cevenini, E., Caruso, C., Candore, G., Capri, M., Nuzzo, D., Duro, G., Rizzo, C., Colonna-Romano, G., Lio, D., Carlo, D., et al. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210790883840 · Cited by 167
“This results are further confirmed in obese mice lacking TNF- or its receptor that show protection against developing insulin resistance [50].”
ResultAlisi, A., Carpino, G., Oliveira, F. L., Panera, N., Nobili, V., & Gaudio, E. (2017) · Mediators of Inflammation · doi:10.1155/2017/8162421 · Cited by 167
“This focus is relevant because it may help researchers that approach clinical and experimental studies on this disease advancing the knowledge of mechanisms that could be targeted in order to revert NAFLD-related fibrosis.”
BackgroundWnt10b Inhibits Obesity in ob/ob and Agouti Mice
Wright, W. S., Longo, K. A., Dolinsky, V. W., Gerin, I., Kang, S., Bennett, C. N., Chiang, S.-H., Prestwich, T. C., Gress, C., Burant, C. F., et al. (2007) · Diabetes · doi:10.2337/db06-1339 · Cited by 167
Long-Term Calorie Restriction Enhances Cellular Quality-Control Processes in Human Skeletal Muscle
Yang, L., Licastro, D., Cava, E., Veronese, N., Spelta, F., Rizza, W., Bertozzi, B., Villareal, D. T., Hotamisligil, G. S., Holloszy, J. O., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.042 · Cited by 166
“Serum cortisol concentration was inversely correlated with serum tumor necrosis factor alpha (TNF-a) concentrations, a critical inflammatory mediator with implications for age-related and metabolic pathologies (Wu et al., 2007; Uysal et al., 1997; De Taeye et al., 2007), in the CR group (Figure 1B), supporting an in v…”
BackgroundWaterman, C., Rojas‐Silva, P., Tumer, T. B., Kuhn, P., Richard, A. J., Wicks, S., Stephens, J. M., Wang, Z., Mynatt, R., Cefalu, W., et al. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400679 · Cited by 166
State of the union between metabolism and the immune system in type 2 diabetes
Nikolajczyk, B. S., Jagannathan-Bogdan, M., Shin, H., & Gyurko, R. (2011) · Genes & Immunity · doi:10.1038/gene.2011.14 · Cited by 166
Adipokines as Drug Targets in Diabetes and Underlying Disturbances
Andrade-Oliveira, V., Câmara, N. O. S., & Moraes-Vieira, P. M. (2015) · Journal of Diabetes Research · doi:10.1155/2015/681612 · Cited by 166
“Importantly, this adipokine is not exclusively produced by adipose tissue [88].”
BackgroundAdipose Tissue Inflammation in the Pathogenesis of Type 2 Diabetes
Kohlgruber, A. C., & Lynch, L. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0670-x · Cited by 177
The immune system's involvement in obesity-driven type 2 diabetes
Shu, C. J., Benoist, C., & Mathis, D. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.12.001 · Cited by 165
Lymphocytes in obesity-related adipose tissue inflammation
Chatzigeorgiou, A., Karalis, K. P., Bornstein, S. R., & Chavakis, T. (2012) · Diabetologia · doi:10.1007/s00125-012-2607-0 · Cited by 175
“Initial findings demonstrated the presence of TNF-α in adipose tissue and its role in mediating insulin resistance [10, 11].”
BackgroundThe physiology of optimizing health with a focus on exercise as medicine
Pedersen, B. K. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114339 · Cited by 163
Insulin resistance in type 2 diabetes mellitus
Accili, D., Deng, Z., & Liu, Q. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01114-y · Cited by 163
“This finding suggests that TNF signalling normally antagonizes insulin signalling by way of JNK phosphorylation, and that inhibiting TNF signalling can restore insulin sensitivity 130 .”
White, M. F. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y06-008 · Cited by 163
Establishment of a concept of visceral fat syndrome and discovery of adiponectin
MATSUZAWA, Y. (2010) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.86.131 · Cited by 163
Sishi, B., Loos, B., Ellis, B., Smith, W., du Toit, E. F., & Engelbrecht, A.-M. (2011) · Experimental Physiology · doi:10.1113/expphysiol.2010.054189 · Cited by 162
“The elevated plasma TNF-α levels observed in our obese rodent model have also been reported by several other researchers (Uysal et al. 1997; Dzienis-Straczkowska et al. 2003; Lo et al. 2007).”
Inflammation arising from obesity reduces taste bud abundance and inhibits renewal
Kaufman, A., Choo, E., Koh, A., & Dando, R. (2018) · PLOS Biology · doi:10.1371/journal.pbio.2001959 · Cited by 162
Ectopic fat accumulation and metabolic syndrome
Rasouli, N., Molavi, B., Elbein, S. C., & Kern, P. A. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00590.x · Cited by 162
Aoki, N., Jin-no, S., Nakagawa, Y., Asai, N., Arakawa, E., Tamura, N., Tamura, T., & Matsuda, T. (2007) · Endocrinology · doi:10.1210/en.2006-1479 · Cited by 162
RetractedRole of Heme Oxygenase in Inflammation, Insulin-Signalling, Diabetes and Obesity
Ndisang, J. F. (2010) · Mediators of Inflammation · doi:10.1155/2010/359732 · Cited by 173
Insulin Resistance, Obesity, Hypertension, and Renal Sodium Transport
Horita, S., Seki, G., Yamada, H., Suzuki, M., Koike, K., & Fujita, T. (2011) · International Journal of Hypertension · doi:10.4061/2011/391762 · Cited by 162
“reported that mice lacking TNFα function do not develop obesity-induced insulin resistance [58].”
BackgroundKetogenesis activates metabolically protective γδ T cells in visceral adipose tissue
Goldberg, E. L., Shchukina, I., Asher, J. L., Sidorov, S., Artyomov, M. N., & Dixit, V. D. (2020) · Nature Metabolism · doi:10.1038/s42255-019-0160-6 · Cited by 161
Harada, K., Shen, W.-J., Patel, S., Natu, V., Wang, J., Osuga, J.-I., Ishibashi, S., & Kraemer, F. B. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00259.2003 · Cited by 161
“Another possible mechanism contributing to the potential insulin resistance in HSL / mice is the apparent upregulation of adipose tissue TNF- , a cytokine associated with inflammation and known to cause insulin resistance (34).”
BackgroundDi Gregorio, G. B., Hensley, L., Lu, T., Ranganathan, G., & Kern, P. A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00189.2003 · Cited by 161
Prevention of skeletal muscle insulin resistance by dietary cod protein in high fat-fed rats
Lavigne, C., Tremblay, F., Asselin, G., Jacques, H., & Marette, A. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.1.e62 · Cited by 161
Akhavan Rezayat, A., Dadgar Moghadam, M., Ghasemi Nour, M., Shirazinia, M., Ghodsi, H., Rouhbakhsh Zahmatkesh, M. R., Tavakolizadeh Noghabi, M., Hoseini, B., & Akhavan Rezayat, K. (2018) · SAGE Open Medicine · doi:10.1177/2050312117745223 · Cited by 151
Insulin resistance induced by tumor necrosis factor-α in myocytes and brown adipocytes12
Lorenzo, M., Fernández-Veledo, S., Vila-Bedmar, R., Garcia-Guerra, L., De Alvaro, C., & Nieto-Vazquez, I. (2008) · Journal of Animal Science · doi:10.2527/jas.2007-0462 · Cited by 156
Fuchs, A., Samovski, D., Smith, G. I., Cifarelli, V., Farabi, S. S., Yoshino, J., Pietka, T., Chang, S.-W., Ghosh, S., Myckatyn, T. M., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.05.008 · Cited by 160
Bradley, R. L., Fisher, F. M., & Maratos‐Flier, E. (2008) · Obesity · doi:10.1038/oby.2008.39 · Cited by 160
Mechanisms of obesity and related pathology: linking immune responses to metabolic stress
Karalis, K. P., Giannogonas, P., Kodela, E., Koutmani, Y., Zoumakis, M., & Teli, T. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07304.x · Cited by 160
Satapathy, S. K., Sakhuja, P., Malhotra, V., Sharma, B. C., & Sarin, S. K. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04756.x · Cited by 160
Nakajima, A., Nakatani, A., Hasegawa, S., Irie, J., Ozawa, K., Tsujimoto, G., Suganami, T., Itoh, H., & Kimura, I. (2017) · PLOS ONE · doi:10.1371/journal.pone.0179696 · Cited by 150
Hypothalamic inflammation: a double‐edged sword to nutritional diseases
Cai, D., & Liu, T. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06388.x · Cited by 159
Role of T Cells in Malnutrition and Obesity
Gerriets, V. A., & MacIver, N. J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00379 · Cited by 145
TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice
Wandrer, F., Liebig, S., Marhenke, S., Vogel, A., John, K., Manns, M. P., Teufel, A., Itzel, T., Longerich, T., Maier, O., et al. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2411-6 · Cited by 152
Transgenic Approach to the Study of Body Weight Regulation
Inui, A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01435-2 · Cited by 175
“The absence of TNF-a due to targeted disruption of the gene does not prevent the development of obesity induced by a high fat or high calory diet, or gold thioglucose injection except for a small decrease in adiposity (Uysal et al., 1997; Ventre et al., 1997).”
BackgroundLee, J. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0023-8 · Cited by 158
“The role of TNFa in the development of insulin resistance was tested subsequently in vivo in obese murine models, first by using a neutralizing TNFa antibody and then by using TNFa receptor knockout mice (Hotamisligil et al. 1993; Uysal et al. 1997, 1998).”
β3-Adrenergic receptor downregulation leads to adipocyte catecholamine resistance in obesity
Valentine, J. M., Ahmadian, M., Keinan, O., Abu-Odeh, M., Zhao, P., Zhou, X., Keller, M. P., Gao, H., Yu, R. T., Liddle, C., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci153357 · Cited by 130
Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison?
Gruben, N., Shiri‐Sverdlov, R., Koonen, D. P. Y., & Hofker, M. H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.08.004 · Cited by 169
“In several studies, mice lacking Tnfr 1 and/or 2 or tumor necrosis factorα (Tnfα) were protected against the development of systemic insulin resistance [80,81].”
BackgroundPeriodontal disease: the influence of metabolic syndrome
Marchetti, E., Monaco, A., Procaccini, L., Mummolo, S., Gatto, R., Tetè, S., Baldini, A., Tecco, S., & Marzo, G. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-88 · Cited by 184
New aspects of the hormone and cytokine response to training
Steinacker, J. M., Lormes, W., Reissnecker, S., & Liu, Y. (2004) · European Journal of Applied Physiology · doi:10.1007/s00421-003-0960-x · Cited by 196
“See also Kirwan and Jing (2002), Pedersen et al. (2001a) and Steinacker et al. (2002) GLUT4 in adipocytes, hepatocytes and skeletal muscle (Coppack 2001; Kirwan and Jing 2002; Lehmann et al. 2000; Mantzoros et al. 1997; Uysal et al. 1997).”
Toll-like receptors regulate B cell cytokine production in patients with diabetes
Jagannathan, M., McDonnell, M., Liang, Y., Hasturk, H., Hetzel, J., Rubin, D., Kantarci, A., Van Dyke, T. E., Ganley-Leal, L. M., & Nikolajczyk, B. S. (2010) · Diabetologia · doi:10.1007/s00125-010-1730-z · Cited by 156
“diabetes-linked cytokine [45].”
Romanatto, T., Roman, E. A., Arruda, A. P., Denis, R. G., Solon, C., Milanski, M., Moraes, J. C., Bonfleur, M. L., Degasperi, G. R., Picardi, P. K., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.030874 · Cited by 147
RetractedKabayama, K. (2004) · Glycobiology · doi:10.1093/glycob/cwh135 · Cited by 155
Xu, H., Sethi, J. K., & Hotamisligil, G. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26287 · Cited by 155
Kim, J.-H., Kim, J. E., Liu, H.-Y., Cao, W., & Chen, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708568200 · Cited by 154
Obesity and cancer, a case for insulin signaling
Poloz, Y., & Stambolic, V. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.381 · Cited by 165
Cheung, A. T., Ree, D., Kolls, J. K., Fuselier, J., Coy, D. H., & Bryer-Ash, M. (1998) · Endocrinology · doi:10.1210/endo.139.12.6336 · Cited by 154
Takahashi, N., Kawada, T., Yamamoto, T., Goto, T., Taimatsu, A., Aoki, N., Kawasaki, H., Taira, K., Yokoyama, K. K., Kamei, Y., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200585200 · Cited by 151
Adipose tissue macrophage in obesity-associated metabolic diseases
Yao, J., Wu, D., & Qiu, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.977485 · Cited by 159
Mechanisms linking obesity and cancer
Louie, S. M., Roberts, L. S., & Nomura, D. K. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.02.008 · Cited by 147
SOCS proteins causing trouble in insulin action
Lebrun, P., & Van Obberghen, E. (2008) · Acta Physiologica · doi:10.1111/j.1748-1716.2007.01782.x · Cited by 141
“Interestingly, the authors showed in the same study that introduction of antisense oligonucleotides for SOCS-1 and SOCS-3 in insulin-resistant db/db mice partially restores the level of IRS tyrosine phosphorylation and increases the insulin signal (Uysal et al. 1997, Ueki et al. 2005).”
BackgroundToll-like receptors, inflammation, metabolism and obesity
Fresno, M., Alvarez, R., & Cuesta, N. (2011) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2011.562514 · Cited by 148
“However, the specific role played by individual pro-inflammatory cytokines in IR is mostly unresolved, except for TNF where there is a great deal of evidence suggesting a crucial role in promoting obesityinduced IR (Hotamisligil et al., 1993; Uysal et al., 1997).”
BackgroundCD11c Expression in Adipose Tissue and Blood and Its Role in Diet-Induced Obesity
Wu, H., Perrard, X. D., Wang, Q., Perrard, J. L., Polsani, V. R., Jones, P. H., Smith, C. W., & Ballantyne, C. M. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.198044 · Cited by 138
Luria, A., Bettaieb, A., Xi, Y., Shieh, G.-J., Liu, H.-C., Inoue, H., Tsai, H.-J., Imig, J. D., Haj, F. G., & Hammock, B. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103482108 · Cited by 155
Characterising metabolically healthy obesity in weight-discordant monozygotic twins
Naukkarinen, J., Heinonen, S., Hakkarainen, A., Lundbom, J., Vuolteenaho, K., Saarinen, L., Hautaniemi, S., Rodríguez, A., Frühbeck, G., Pajunen, P., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3066-y · Cited by 163
“In rodents, knocking out genes that are involved in the formation of the inflammatory response prevent the development of type 2 diabetes [47–49] and in humans, use of antiinflammatorymedications improves glycaemic control in type 2 diabetes and obesity [50].”
BackgroundTNF- , chronic hepatitis C and diabetes: a novel triad
Knobler, H., & Schattner, A. (2005) · QJM · doi:10.1093/qjmed/hci001 · Cited by 148
Liao, W., Nguyen, M. T. A., Yoshizaki, T., Favelyukis, S., Patsouris, D., Imamura, T., Verma, I. M., & Olefsky, J. M. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00695.2006 · Cited by 142
Hypothalamic dysfunction in obesity
Williams, L. M. (2012) · Proceedings of the Nutrition Society · doi:10.1017/s002966511200078x · Cited by 146
Intestinal microbiota and the immune system in metabolic diseases
Sittipo, P., Lobionda, S., Lee, Y. K., & Maynard, C. L. (2018) · Journal of Microbiology · doi:10.1007/s12275-018-7548-y · Cited by 141
“Obese mice have more ATMs, which largely produce tumor necrosis factor alpha (TNF-α) and are associated with insulin resistance (Uysal et al., 1997; Weisberg et al., 2003).”
BackgroundKumari, R., Kumar, S., & Kant, R. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.06.005 · Cited by 167
Knobler, H. (2003) · The American Journal of Gastroenterology · doi:10.1016/j.amjgastroenterol.2003.06.002 · Cited by 148
Tiffin, N. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl381 · Cited by 145
Metabolic Syndrome and Robustness Tradeoffs
Kitano, H., Oda, K., Kimura, T., Matsuoka, Y., Csete, M., Doyle, J., & Muramatsu, M. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s6 · Cited by 146
Coccurello, R., & Moles, A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.008 · Cited by 163
“Indeed, in leptin deficient ob/ob mice and in DIO models, the lack of TNF-α receptors was shown to protect against insulin resistance (Uysal et al., 1997).”
BackgroundLymphotoxin regulates commensal responses to enable diet-induced obesity
Upadhyay, V., Poroyko, V., Kim, T.-J., Devkota, S., Fu, S., Liu, D., Tumanov, A. V., Koroleva, E. P., Deng, L., Nagler, C., et al. (2012) · Nature Immunology · doi:10.1038/ni.2403 · Cited by 143
Tumor necrosis factor α and insulin resistance in obese type 2 diabetic patients
Miyazaki, Y., Pipek, R., Mandarino, L. J., & DeFronzo, R. A. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802187 · Cited by 167
Metadata
- Authors
- Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S.
- Affiliations
- Harvard University (US)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Hotamisligil, Gkhan S.
- Venue
- Nature
- Published
- 1997-10
- Volume
- 389
- Issue
- 6651
- Pages
- 610-614
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1764140709
- Cited by
- 2,234
- References
- 26
- Citations by year
- 2026: 15 · 2025: 39 · 2024: 40 · 2023: 48 · 2022: 50 · 2021: 77 · 2020: 79 · 2019: 79 · 2018: 80 · 2017: 96 · 2016: 71 · 2015: 111 · 2014: 106 · 2013: 141 · 2012: 122
- FWCI
- 33.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- TNF-α, insulin resistance, obesity, diet-induced obesity, ob/ob mice, free fatty acids, insulin receptor signaling, type 2 diabetes, adipose tissue, skeletal muscle
- MeSH terms
- Adipose Tissue, Animals, Fatty Acids, Glucose, Glucose Tolerance Test, Homeostasis, Insulin Resistance, Male, Mice, Inbred C57BL, Mice, Obese, Monosaccharide Transport Proteins, Muscle Proteins, Mutation, Obesity, Phosphorylation, Receptor, Insulin, Triglycerides, Tumor Necrosis Factor-alpha, Signal Transduction, Receptors, Tumor Necrosis Factor, Glucose Transporter Type 4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.